MATTISON GORRELL: Open Payments
NPI 1629470265 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 57 payments from 12 companies in 2025. Trend: 2023 $604 · 2024 $1,270 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $184 |
| GlaxoSmithKline, LLC. | 14 | $175 |
| AstraZeneca Pharmaceuticals LP | 7 | $147 |
| Lilly USA, LLC | 5 | $103 |
| PFIZER INC. | 5 | $95 |
| Amgen Inc. | 5 | $93 |
| Exact Sciences Corporation | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $25 |
Products named: TRELEGY ELLIPTA, FARXIGA, MOUNJARO, NURTEC ODT, EVENITY, Ozempic, Wegovy, Auvelity.
Industry payments across NY — which companies pay providers there.
